Growing xenografted tumors in endothelial–specific Dll4 loss-of-function mice revealed that despite being highly hypoxic, these tumors displayed reduced numbers of cancer stem cells and reduced levels of EMT, when compared to mice with normal expression of Dll4. In turn, this led to reduced numbers of circulating tumor cells and lung metastases [137]. This evidence concerns the gene DLL4 and cancer.